Table 1 Comparison of patient demographics for patients with POAF and NSR following CABG/OPCAB ± AVR in Iceland between 2002 and 2006
From: Atrial fibrillation following cardiac surgery: risk analysis and long-term survival
POAF (n = 326) | NSR (n = 418) | p-value | |
|---|---|---|---|
Male (%) | 244 (74) | 349 (83) | 0.005 |
Age in years, mean ± SD | 70 ± 9.3 | 64 ± 8.7 | < 0.001 |
Diabetes (%) | 62 (19) | 60 (14) | 0.11 |
Hypertension (%) | 213 (65) | 248 (59) | 0.11 |
Dyslipidemia (%) | 161 (49) | 263 (63) | < 0.001 |
Smoking history (%) | 58 (18) | 111 (35) | 0.005 |
Chronic heart failure (%) | 66 (20) | 35 (8) | < 0.001 |
Mean number of affected vessels | 2.4 | 2.7 | < 0.001 |
Mean left ventricular ejection fraction (LVEF) | 51 | 55 | < 0.001 |
Mean EuroSCORE | 6.0 | 4.0 | < 0.001 |
β blocker use preoperatively (%) | 201 (62) | 291 (70) | 0.074 |
Ca2+ channel blocker use preoperatively (%) | 67 (21) | 80 (19) | 0.58 |
Statin use preoperatively (%) | 201 (63) | 316 (76) | < 0.001 |